Xihua Pharma 上海熙华药业有限公司

shanghai xihua pharma is a wholly-owned subsidiary of shanghai xihua scientific. xihua pharma cdmo platform consists of shanghai xihuapharma r&d, shanghai xihua pharmatech, fujian xihua pharma and primera in the us. at present, we have more than 5,400 m² laboratory space, 120,000 m² factories under construction and more than 120 employees in china. shanghai xihua pharma r&d teams provide services including api process r&d and scale-up, analytical for small & large molecules as well as gene and cell therapy products (gctp), innovative formulation development, clinical supplies manufacturing and commercial formulation manufacturing, and regulatory affairs services. shanghai xihuapharmatech is focused on generic products development including formulation process r&d, scale-up, technology transfer, analytical support and regulatory affairs services. fujian xihua pharma is engaged in process r&d and commercial manufacturing of advanced intermediates and api. the plant under constr